With a background in Preclinical Pharmacology, Muhammed obtained his PhD from the University of South Australia. Currently, he is working as a postdoctoral researcher at the Cancer Pharmacogenomics Laboratory at the Centre for Cancer Biology. His research focuses on genomic instability in cancer cells and utilizing this to identify new drug targets for treatment. He previously worked with Professor Shudong Wang in the Drug Discovery and Development group at the University of South Australia. He has extensive experience in the preclinical development of novel anti-cancer targeted agents, particularly cyclin-dependent kinase inhibitors, using both in vitro and in vivo models of cancer.
About me
With a background in Preclinical Pharmacology, Muhammed obtained his PhD from the University of South Australia. Currently, he is working as a postdoctoral researcher at the Cancer Pharmacogenomics Laboratory at the Centre for Cancer Biology. His research focuses on genomic instability in cancer cells and utilizing this to identify new drug targets for treatment. He previously worked with Professor Shudong Wang in the Drug Discovery and Development group at the University of South Australia. He has extensive experience in the preclinical development of novel anti-cancer targeted agents, particularly cyclin-dependent kinase inhibitors, using both in vitro and in vivo models of cancer.
About me
Doctor of Philosophy University of South Australia
Master of Science University of Rajshahi
Bachelor of Science (Honours) University of Rajshahi
Research
Excludes commercial-in-confidence projects.
Targeting cyclin-dependent kinase 4 in glioblastoma, Neurosurgical Research Foundation, 24/08/2020 - 21/08/2021
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2025 |
Open access
|
| 2024 |
Open access
3
4
107
|
| 2023 |
Open access
2
1
3
|
| 2021 |
Open access
14
12
1
|
| 2020 |
26
25
1
|
| 2019 |
Open access
45
42
|
| 2019 |
33
32
3
|
| 2017 |
Open access
23
21
|
| 2017 |
Open access
68
62
9
|
| 2016 |
Open access
63
58
5
|
| 2014 |
Open access
|
| 2014 |
Open access
|
| 2012 |
Open access
3
|
| 2011 |
Open access
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Bangladesh Council of Scientific and Industrial Research | BANGLADESH |
| Cardiff University | UNITED KINGDOM |
| Flinders University | AUSTRALIA |
| Monash University | AUSTRALIA |
| Shahjalal University of Science and Technology | BANGLADESH |
| Shandong University | CHINA |
| University of Adelaide | AUSTRALIA |
| University of New South Wales | AUSTRALIA |
| University of Newcastle | AUSTRALIA |
| University of Rajshahi | BANGLADESH |
| University of South Australia | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| New drugs to treat brain cancer | Current |
| Preclinical evaluation of TAM kinase inhibitors as potential anticancer agents | Completed |
